• Skip navigation
  • Skip to navigation
  • Skip to the bottom
Simulate organization breadcrumb open Simulate organization breadcrumb close
German Chronic Kidney Disease (GCKD)
Suche öffnen
  • Deutsch
  • English
  • Medizin 4
  • Askimed-GCKD

German Chronic Kidney Disease (GCKD)

Navigation Navigation close
  • About the Team
    • Steering commitee
    • Coordinating center
    • Regional teams
    • Cooperating institutions
    • University centers
    • Cooperating study sites
    Portal About the Team
  • About the Study
    • Study Participants
    • Previous Study Results
      • Event Analysis
    Portal About the Study
  • Partner
    • International cooperations
    • Industrial Partners
    • Biobank consortium
    Portal Partner
  • Publications
    • 2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2010-2013
    Portal Publications
  1. Home
  2. Partner
  3. International cooperations

International cooperations

In page navigation: Partner
  • International cooperations
    • CKD-PC und INet CKD
    • BEAt-DKD
    • Prime-CKD
  • Industrial Partners
  • Biobank consortium

International cooperations

The GCKD-Study is aimed at achieving broad comprehension of disease progresssion and gaining further knowledge in cooperation with other international cohort projects in renal populations.
Existing collaborations comprise:

  • national cohort-study in the USA (CRIC = Chronic Renal Insufficiency Cohort; Leiter: Dr. Harv Feldman, Philadelphia) initiated in 2003, approx. 4000 Patients enrolled
  • national cohort-study in Japan (CKD-JAC = Chronic Kidney Disease-Japan Cohort; Leiter: Dr. Enuy Imai, Nagoya) initiated in 200..,approx. 3000 Patients enrolled
  • national cohort-study in India
    (ICKD = Indian Chronic Kidney Disease Study, PI: Dr. Seema Baid-Agrawal, Berlin, Dr. V.Jha , Chandigarh), expected to be initiated in 2012, approx. 5000 patients planned

The inclusion criteria and the structure of these studies are similar. Especially, the definitions of disease entities, the diagnoses and the endpoints have been designed along the lines of the CRIC-study to achieve comparability and allow pooled analyses with increased statistical power, and open the possibilities of comparing risk factors and disease progression in different racial, cultural and ethnical backgrounds.

Universitätsklinikum Erlangen
GCKD Study center

Ulmenweg 18
91054 Erlangen
Germany
  • Imprint
  • Privacy
  • Accessibility
  • Facebook
  • RSS Feed
  • Twitter
  • Xing
Up